# A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

> clinical trial · VERIFIED · 2026-07-30

Status: TERMINATED · Sponsor: M.D. Anderson Cancer Center · Condition: Leukemia

- Company: M.D. Anderson Cancer Center
- Sector: Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT06021600

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.